Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CITIC Medical Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 7
Rounds per year 1.00
Lead investments 2
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Manufacturing
  • Health Diagnostics
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CITIC Medical Fund:
Typical Co-investors
CITIC Medical Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CITIC Medical Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Automagi Japan, Tokyo
Benefit China Asset Management Beijing, Beijing, China
Coface Bois-colombes, France, Ile-de-France
E-Synergy California, Los Angeles, United States
Envy Capital Farmington Hills, Michigan, United States
Federal-Mogul Motorparts -
FengHe Fund Management China, Guangdong Province, Huangpu District
frontierCities Belgium, Brussels, Brussels Hoofdstedelijk Gewest
Gradiente Sgr Italy, Padua, Veneto
Innovent California, United States, Walnut Creek
Meridian Asset Management Salt Lake City, United States, Utah
Morningside Capital Chicago, Illinois, United States
OneEleven Canada, Ontario, Toronto
Pangmao VC China, Shanghai
Reliance Industries India, Maharashtra, Mumbai
Rhodes Partners Bethesda, Maryland, United States
Sathguru Catalyzer Advisors Andhra Pradesh, Hyderabad, India
Shanghai Quanli Touzi China, Shanghai
Solactive Frankfurt, Germany, Hessen
Upscale England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Raisecare

Biotechnology
Health Care
Health Diagnostics
Medical
$15M03 Nov 2023 Qingdao Shi, Shandong, China

Aikeda Bio

Health Care
Health Diagnostics
Service Industry
01 Sep 2023 China, China

Jyss Bio

25 Jul 2021 Hangzhou, Zhejiang, China

Simcere Pharma

Biotechnology
Manufacturing
$92M04 Jun 2021 Xuanwu District, Jiangsu, China

YiChao YiLiao

Health Care
01 Feb 2021 Shanghai, China

Raynovent

Biotechnology
$43M15 Dec 2020 Guangzhou, Guangdong, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CITIC Medical Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 21M
Rounds per year 1.00
Peak activity year 2021
Lead investments 2
Exits 2
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Raisecare

Biotechnology
Health Care
Health Diagnostics
Medical
$15M03 Nov 2023 Qingdao Shi, Shandong, China

Aikeda Bio

Health Care
Health Diagnostics
Service Industry
01 Sep 2023 China, China

Jyss Bio

25 Jul 2021 Hangzhou, Zhejiang, China

Simcere Pharma

Biotechnology
Manufacturing
$92M04 Jun 2021 Xuanwu District, Jiangsu, China

YiChao YiLiao

Health Care
01 Feb 2021 Shanghai, China

Raynovent

Biotechnology
$43M15 Dec 2020 Guangzhou, Guangdong, China
Crunchbase icon

Content report

The following text will be sent to our editors: